Skip to main content
Screener/Healthcare/Biotechnology

DNLI — Denali Therapeutics Inc.

NASDAQ
$19.80+0.37 (+1.90%)
Mid CapUnder $20Healthcare
$12.58
$23.77
$19.27
$20.05
EPS (TTM)$-2.97
P/E Ratio—
Dividend Yield—
Market Cap$3.28B
Volume649K
Prev Close$19.45
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$128.5M$-0.73——
Q3 '25$0-$126.9M$-0.74——
Q2 '25$0-$124.1M$-0.72——
Q1 '25$0-$133.0M$-0.78——
Q4 '24$0-$114.8M$-0.67——
Q3 '24$0-$107.2M$-0.63——
Q2 '24$0-$99.0M$-0.59——
Q1 '24$0-$101.8M$-0.68——
Get Your Daily Market Recap